Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effect of Tocilizumab Versus Methotrexate on Major Adverse Cardiovascular Events in Giant Cell Arteritis: A Nationwide Target Trial Emulation Using the French SNDS

NCT07459335 is registered in ClinicalTrials.gov with Groupe français d'étude des Maladies Inflammatoires de loeil as lead sponsor.

NCT NCT07459335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07459335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effect of Tocilizumab Versus Methotrexate on Major Adverse Cardiovascular Events in Giant Cell Arteritis: A Nationwide Target Trial Emulation Using the French SNDS
Lead sponsor
Groupe français d'étude des Maladies Inflammatoires de loeil
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
December 31, 2024
Enrollment
1,667 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, giant cell arteritis (gca)